Seek Returns

JNJ vs. TSLA: Johnson & Johnson vs. Tesla Stock Comparison

How do Johnson & Johnson (JNJ) and Tesla (TSLA) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.

Company Profile

Johnson & Johnson (JNJ) is classified in the Health Care sector (Pharmaceuticals, Biotechnology & Life Sciences), whereas Tesla (TSLA) belongs to Consumer Discretionary (Automobiles & Components) — their GICS classifications point to very different parts of the market.

Company profile comparison for Johnson & Johnson (JNJ) and Tesla (TSLA)
Profile ItemJNJTSLA
NameJohnson & JohnsonTesla, Inc.
Country/RegionUnited StatesUnited States
GICS SectorHealth CareConsumer Discretionary
GICS Industry GroupPharmaceuticals, Biotechnology & Life SciencesAutomobiles & Components
GICS IndustryPharmaceuticalsAutomobiles
GICS Sub-IndustryPharmaceuticalsAutomobile Manufacturers
Market Capitalization664.95 billion USD1,415.96 billion USD
CurrencyUSDUSD
ExchangeNYSENasdaq
Listing DateJanuary 2, 1962June 29, 2010
Security TypeCommon StockCommon Stock

Price Performance

Cumulative Growth

JNJ
TSLA
GSPC
Loading price history…
Johnson & Johnson (JNJ) vs. Tesla (TSLA), with S&P 500 (GSPC) for reference: Growth of a $10,000 investment over the past five years. Adjusted for dividends and splits.

Trailing Returns

Loading price history…
Trailing total returns for Johnson & Johnson (JNJ) and Tesla (TSLA). Returns over one year are annualized.

Calendar-Year Returns

Loading price history…
Calendar-year total returns for Johnson & Johnson (JNJ) and Tesla (TSLA). Each bar is that year's total return, measured year-end to year-end.

Performance Metrics

Price performance metrics for Johnson & Johnson (JNJ) and Tesla (TSLA)
MetricJNJTSLA
Total Return (1Y)53.82%-12.23%
Total Return (3Y, Annualized)27.51%21.54%
Total Return (5Y, Annualized)14.71%2.02%

Risk Profile

Drawdown History

JNJ
TSLA
GSPC
Loading price history…
Johnson & Johnson (JNJ) vs. Tesla (TSLA), with S&P 500 (GSPC) for reference: Drawdown from the running peak over the past five years. Each line shows the decline from its prior peak; 0% marks a new high.

Return Distribution

Loading price history…
Distribution of monthly total returns for Johnson & Johnson (JNJ) and Tesla (TSLA). Each bar is the share of months whose return fell in that 5% bucket.

Risk Metrics

Tesla (TSLA) has an aggressive beta of 1.75, indicating higher sensitivity to broad-market moves, while Johnson & Johnson (JNJ) is defensive at 0.21 and tends to be less market-sensitive — they sit on opposite ends of the beta spectrum.

Risk profile metrics for Johnson & Johnson (JNJ) and Tesla (TSLA)
MetricJNJTSLA
Volatility (1Y, Annualized)21.23%45.89%
Beta (5Y)0.211.75
Max Drawdown (5Y)-18.41%-72.97%
Avg. Volume (3M)6.93M37.45M

Risk-Adjusted Performance

Risk-Return Positioning

Loading chart…
JNJ and TSLA are plotted by 1-year volatility (risk) and 1-year return. Each dashed Capital Allocation Line uses that stock's own industry median.

Risk-Adjusted Metrics

Risk-adjusted metrics for Johnson & Johnson (JNJ) and Tesla (TSLA)
MetricJNJTSLA
Sharpe Ratio (1Y)2.33-0.36
Sortino Ratio (1Y)3.66-0.49

Profitability

ROE (TTM)

Johnson & Johnson (JNJ) at 20.02% sits in the top ROE quartile, while Tesla (TSLA) at 3.84% is closer to the peer norm — stronger capital efficiency for JNJ.

JNJ

Pharmaceuticals, Biotechnology & Life Sciences industry group

20.02%

Max
109.18%
JNJ
20.02%
Q3
6.23%
Median
-26.66%
Q1
-64.05%
Min
-167.77%

TSLA

Automobiles & Components industry group

3.84%

Max
43.84%
Q3
11.73%
TSLA
3.84%
Median
3.48%
Q1
-19.67%
Min
-54.88%
Loading chart…
Johnson & Johnson (JNJ) vs. Tesla (TSLA): A comparison of their ROE against their respective Pharmaceuticals, Biotechnology & Life Sciences and Automobiles & Components industry group benchmarks.

Net Margin (TTM)

Johnson & Johnson (JNJ) at 16.20% retains a top-quartile share of revenue as profit, ahead of Tesla (TSLA) at 3.11%, which keeps about the industry-typical share.

JNJ

Pharmaceuticals, Biotechnology & Life Sciences industry group

16.20%

Max
18.05%
JNJ
16.20%
Q3
4.78%
Median
0.00%
Q1
-4.14%
Min
-17.05%

TSLA

Automobiles & Components industry group

3.11%

Max
15.15%
Q3
4.78%
TSLA
3.11%
Median
1.56%
Q1
-4.16%
Min
-9.55%
Loading chart…
Johnson & Johnson (JNJ) vs. Tesla (TSLA): A comparison of their net margin against their respective Pharmaceuticals, Biotechnology & Life Sciences and Automobiles & Components industry group benchmarks.

Operating Margin (TTM)

Johnson & Johnson (JNJ) at 25.74% operates in the top operating margin quartile, ahead of Tesla (TSLA) at 5.36%, which runs around its industry’s norm.

JNJ

Pharmaceuticals, Biotechnology & Life Sciences industry group

25.74%

Max
83.12%
JNJ
25.74%
Q3
14.77%
Median
0.00%
Q1
-78.82%
Min
-207.40%

TSLA

Automobiles & Components industry group

5.36%

Max
18.35%
Q3
8.67%
TSLA
5.36%
Median
4.42%
Q1
0.00%
Min
-8.50%
Loading chart…
Johnson & Johnson (JNJ) vs. Tesla (TSLA): A comparison of their operating margin against their respective Pharmaceuticals, Biotechnology & Life Sciences and Automobiles & Components industry group benchmarks.

Profitability Metrics

Profitability metrics for Johnson & Johnson (JNJ) and Tesla (TSLA)
MetricJNJTSLA
ROE (TTM)20.02%3.84%
ROA (TTM)8.46%1.35%
Net Margin (TTM)16.20%3.11%
Operating Margin (TTM)25.74%5.36%
Gross Margin (TTM)67.78%19.29%

Growth

Revenue Growth

Johnson & Johnson (JNJ) at 6.05% is around its peer norm for revenue growth, while Tesla (TSLA) at -2.93% drops into the bottom quartile, signaling weaker demand or pricing momentum.

Loading chart…
Johnson & Johnson (JNJ) vs. Tesla (TSLA): A comparison of their Revenue Growth across different time periods.

EPS Growth

Johnson & Johnson (JNJ) at 90.50% sits in the top EPS growth quartile, while Tesla (TSLA) at -47.06% is closer to the peer norm — faster per-share earnings growth for JNJ.

Loading chart…
Johnson & Johnson (JNJ) vs. Tesla (TSLA): A comparison of their EPS Growth across different time periods.

Growth Metrics

Growth metrics for Johnson & Johnson (JNJ) and Tesla (TSLA)
MetricJNJTSLA
Revenue Growth (YoY)6.05%-2.93%
Revenue Growth (3Y CAGR)5.60%5.19%
EPS Growth (YoY)90.50%-47.06%
EPS Growth (3Y CAGR)17.90%-33.18%

Financial Strength

Current Ratio (MRQ)

Tesla (TSLA) at 1.74 keeps current ratio within its industry’s typical mid-range, while Johnson & Johnson (JNJ) at 1.02 runs in the tighter-liquidity quartile — a thinner cushion against current liabilities for JNJ.

JNJ

Pharmaceuticals, Biotechnology & Life Sciences industry group

1.02

Max
25.13
Q3
12.13
Median
5.52
Q1
2.47
JNJ
1.02
Min
0.10

TSLA

Automobiles & Components industry group

1.74

Max
3.65
Q3
2.31
TSLA
1.74
Median
1.65
Q1
1.13
Min
0.32
Loading chart…
Johnson & Johnson (JNJ) vs. Tesla (TSLA): A comparison of their current ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Automobiles & Components industry group benchmarks.

Debt / Equity (MRQ)

Tesla (TSLA) at 0.18 keeps leverage in the lower industry quartile, while Johnson & Johnson (JNJ) at 0.55 runs a more typical debt-to-equity mix.

JNJ

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.55

Max
1.42
Q3
0.65
JNJ
0.55
Median
0.15
Q1
0.02
Min
0.00

TSLA

Automobiles & Components industry group

0.18

Max
2.03
Q3
1.13
Median
0.76
Q1
0.33
TSLA
0.18
Min
0.01
Loading chart…
Johnson & Johnson (JNJ) vs. Tesla (TSLA): A comparison of their debt-to-equity ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Automobiles & Components industry group benchmarks.

Financial Strength Metrics

Financial strength metrics for Johnson & Johnson (JNJ) and Tesla (TSLA)
MetricJNJTSLA
Current Ratio (MRQ)1.021.74
Debt / Equity (MRQ)0.550.18
Net Debt / EBITDA0.79-2.95

Dividends

Dividend Yield (TTM)

Tesla (TSLA) pays no dividend (yield 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Johnson & Johnson (JNJ) reports a yield of 1.94%, ranking against industry peers normally.

JNJ

Pharmaceuticals, Biotechnology & Life Sciences industry group

1.94%

JNJ
1.94%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%

TSLA

Automobiles & Components industry group

0.00%

Max
4.79%
Q3
2.24%
TSLA
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%
Loading chart…
Johnson & Johnson (JNJ) vs. Tesla (TSLA): A comparison of their dividend yield against their respective Pharmaceuticals, Biotechnology & Life Sciences and Automobiles & Components industry group benchmarks.

Dividend Payout Ratio (TTM)

Tesla (TSLA) pays no dividend (payout 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Johnson & Johnson (JNJ) reports a payout of 80.12%, ranking against industry peers normally.

JNJ

Pharmaceuticals, Biotechnology & Life Sciences industry group

80.12%

JNJ
80.12%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%

TSLA

Automobiles & Components industry group

0.00%

Max
64.17%
Q3
36.51%
TSLA
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%
Loading chart…
Johnson & Johnson (JNJ) vs. Tesla (TSLA): A comparison of their payout ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Automobiles & Components industry group benchmarks.

Dividend Metrics

Dividend metrics for Johnson & Johnson (JNJ) and Tesla (TSLA)
MetricJNJTSLA
Dividend Yield (TTM)1.94%0.00%
Dividend Payout Ratio (TTM)80.12%0.00%

Valuation

P/E Ratio (TTM)

Johnson & Johnson (JNJ) at 41.92 is near its industry’s usual P/E ratio, while Tesla (TSLA) at 393.65 sits above its peer range — an unusually expensive price for TSLA’s trailing earnings.

JNJ

Pharmaceuticals, Biotechnology & Life Sciences industry group

41.92

Max
85.34
Q3
43.46
JNJ
41.92
Median
26.69
Q1
13.30
Min
0.07

TSLA

Automobiles & Components industry group

393.65

TSLA
393.65
Max
40.42
Q3
24.40
Median
19.50
Q1
11.03
Min
6.05
Loading chart…
Johnson & Johnson (JNJ) vs. Tesla (TSLA): A comparison of their P/E ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Automobiles & Components industry group benchmarks.

P/S Ratio (TTM)

Johnson & Johnson (JNJ) at 6.69 prices around its industry’s typical P/S ratio, while Tesla (TSLA) at 13.67 clears its benchmark range — TSLA looks notably rich on sales.

JNJ

Pharmaceuticals, Biotechnology & Life Sciences industry group

6.69

Max
58.18
Q3
25.77
Median
7.30
JNJ
6.69
Q1
3.01
Min
0.01

TSLA

Automobiles & Components industry group

13.67

TSLA
13.67
Max
2.03
Q3
0.99
Median
0.51
Q1
0.23
Min
0.00
Loading chart…
Johnson & Johnson (JNJ) vs. Tesla (TSLA): A comparison of their P/S ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Automobiles & Components industry group benchmarks.

P/B Ratio (MRQ)

Both look rich against book: Johnson & Johnson (JNJ) at 8.16 sits in the upper P/B ratio quartile, and Tesla (TSLA) at 15.86 prices even higher, above its industry range.

JNJ

Pharmaceuticals, Biotechnology & Life Sciences industry group

8.16

Max
13.53
JNJ
8.16
Q3
6.54
Median
3.25
Q1
1.69
Min
-5.59

TSLA

Automobiles & Components industry group

15.86

TSLA
15.86
Max
4.18
Q3
2.39
Median
1.33
Q1
0.72
Min
-1.23
Loading chart…
Johnson & Johnson (JNJ) vs. Tesla (TSLA): A comparison of their P/B ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Automobiles & Components industry group benchmarks.

Valuation Metrics

Valuation metrics for Johnson & Johnson (JNJ) and Tesla (TSLA)
MetricJNJTSLA
P/E Ratio (TTM)41.92393.65
P/S Ratio (TTM)6.6913.67
P/B Ratio (MRQ)8.1615.86
Free Cash Flow Yield (TTM)2.78%0.35%